Emergence of Zidovudine Resistance in HIV-Infected Patients Receiving Stavudine
- 1 March 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 23 (3) , 279-281
- https://doi.org/10.1097/00042560-200003010-00013
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapyAIDS, 1999
- Multiple drug resistance genotype causing failure of antiretroviral treatment in an HIV-infected patient heavily exposed to nucleoside analogues.European Journal of Clinical Microbiology & Infectious Diseases, 1999
- Introduction of HIV drug-resistance testing in clinical practiceAIDS, 1999
- High prevalence of multiple drug resistance mutations in a UK HIV/AIDS patient populationAIDS, 1999
- Effective Salvage Therapy for HIV-1 Infection – An Unmet ChallengeAntiviral Therapy, 1999
- A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors.Journal of Clinical Investigation, 1998
- Line Probe Assay for Detection of Human Immunodeficiency Virus Type 1 Mutations Conferring Resistance to Nucleoside Inhibitors of Reverse Transcriptase: Comparison with Sequence AnalysisJournal of Clinical Microbiology, 1998
- Antiretroviral Drug Resistance Testing in Adults With HIV InfectionJAMA, 1998
- Genotypic and Phenotypic Resistance to Stavudine after Long-Term MonotherapyAntiviral Therapy, 1998
- Comparison Of Metabolism And In Vitro Antiviral Activity Of Stavudine Versus Other 2',3'-Dideoxynucleoside AnaloguesThe Journal of Infectious Diseases, 1995